About
Thierry Jomini, CEO of AbbatiaLabs, is a mechanical engineer with more than 15 years of experience with the development of drug delivery devices and combination products, primarily focusing on sterile products for subcutaneous administration in areas such as diabetes, Parkinson’s disease and hormone therapies.
In 2019, he co-founded Anteris Helvetia, a consulting firm that supports pharma and biotech companies in bringing their drug delivery devices to market, where he served as General Manager. In 2023, Anteris Helvetia was acquired by Kymanox, a US-based company.